WAYNE, Pa., Aug. 07, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: PVLA) Palvella Therapeutics, Inc. (Palvella),...
Palvella Therapeutics (NASDAQ:PVLA) will be releasing its Q2 2025 earnings before the market opens o...
Lifesci Capital initiated coverage on shares of Palvella Therapeutics in a research report on Monday...
WAYNE, Pa., Aug. 05, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: PVLA) Palvella Therapeutics, Inc. (Palvella),...
Shares of Palvella Therapeutics, Inc. (NASDAQ:PVLA – Get Free Report) have been given an average rec...